Harvest Health: Second Quarter Consensus Estimates

Harvest Health and Recreation (CSE: HARV) announced that they will be reporting their second quarter financials after the market closes on August 10.

Analysts have a consensus C$7 12-month price target on the company, via a total of 5 analysts, with one analyst having a strong buy rating, and the other 4 analysts having buy ratings. The street high comes from Alliance Global Partners with a C$9.50 price target, and the lowest target comes from Stifel-GMP with a C$5.50 price target.

Currently 4 analysts have revenue estimates for the second quarter. The mean between all 4 is $97.08 million; this number has been revised slightly higher from $87.08 million at the start of the year. The street high is $98.60 million while the lowest sits at $95.72 million.

Two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 50.55%, with this number being revised slightly downwards from 51.70% at the start of the year. Street high goes to Stifel-GMP with a 53.50% estimate and the lowest sits at 47.60%.

Onto EBITDA estimates, there are currently 3 analysts who have second quarter EBITDA estimates. The mean is currently $26.82 million, with this number being higher than at the start of the year. Street high goes to Alliance Global with a $28.27 million EBITDA estimate and the lowest being a $26 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Valens: Canaccord Maintains $3.50 Price Target Following First Quarter Results

Last week, The Valens Company (TSX: VLNS) reported first quarter financial results. The company reported...

Saturday, April 17, 2021, 12:05:00 PM

PI Financial Initiates Coverage On Gage Growth With C$7.50 Price Target

On Wednesday morning, PI Financial initiated coverage on Gage Growth Corp (CSE: GAGE) with a...

Friday, July 2, 2021, 04:10:00 PM

BMO Reiterates $21 Price Target On Victoria Gold After Production Results

On January 6th, Victoria Gold Corp. (TSX: VGCX) announced its fourth quarter and annual production...

Saturday, January 8, 2022, 01:08:00 PM

Cresco Labs: Analysts Raise Targets Following Blowout Quarter

On November 18th, Cresco Labs (CSE: CL) reported their third quarter financial results. The company...

Friday, November 20, 2020, 12:09:00 PM

Magna International: BMO Lowers Estimates On Lower Production Expectations

On August 16 BMO Capital Markets slightly lowered their 12-month price target on Magna International...

Thursday, August 19, 2021, 10:32:00 AM